Your session is about to expire
← Back to Search
Early Intervention Group for Respiratory Distress Syndrome (LINK Trial)
N/A
Waitlist Available
Led By Gordon D. Rubenfeld, MD
Research Sponsored by Sunnybrook Health Sciences Centre
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up measured at month 6
Awards & highlights
LINK Trial Summary
Acute lung injury/acute respiratory distress syndrome (ALI/ARDS) is a severe lung condition that causes respiratory failure. Individuals with ALI/ARDS often require the use of a respirator or artificial breathing machine, known as a mechanical ventilator, while in an intensive care unit (ICU). Research has shown that lung protective ventilation (LPV), a type of mechanical ventilation technique, is an effective way to reduce the number of deaths due to ALI/ARDS. This study will evaluate the effectiveness of a Web-based educational program that aims to educate ICU clinicians about the use of LPV in patients with ALI/ARDS.
Eligible Conditions
- Respiratory Distress Syndrome
LINK Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ measured at month 6
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~measured at month 6
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Percentage of eligible patients with ALI/ARDS who are receiving LPV
LINK Trial Design
2Treatment groups
Active Control
Group I: Early Intervention GroupActive Control1 Intervention
Group II: Delayed Intervention GroupActive Control1 Intervention
Find a Location
Who is running the clinical trial?
Sunnybrook Health Sciences CentreLead Sponsor
657 Previous Clinical Trials
1,551,191 Total Patients Enrolled
4 Trials studying Respiratory Distress Syndrome
84 Patients Enrolled for Respiratory Distress Syndrome
National Heart, Lung, and Blood Institute (NHLBI)NIH
3,847 Previous Clinical Trials
47,818,406 Total Patients Enrolled
63 Trials studying Respiratory Distress Syndrome
41,132 Patients Enrolled for Respiratory Distress Syndrome
Gordon D. Rubenfeld, MDPrincipal InvestigatorUniversity of Toronto, Sunnybrook Health Sciences
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Share this study with friends
Copy Link
Messenger